Capgemini sees double-digit growth across regions, but clients remain cautious
By Christian Moess Laursen
Capgemini said Thursday that first-quarter revenue rose 10% organically, with double-digit growth in nearly all regions, despite cautious client sentiment.
The French consulting and technology group said revenue was 5.73 billion euros ($6.34 billion), up from EUR5.17 billion in the same quarter of 2022.
Analysts had seen revenue at EUR5.59 billion, according to a consensus estimate provided by FactSet.
The company said most of its regions continued to grow in the double digits at constant exchange rates.
"Capgemini has delivered a very good start to the year, above expectations, in an economic environment that remains tense with some clients adopting a 'wait-and-see' attitude," Chief Executive Officer Aiman Ezzat said.
Capgemini backed its full-year targets of revenue growth between 4% and 7% at constant currencies, operating margin of 13.0% to 13.2% and organic free cash flow around EUR1.8 billion.
Write to Christian Moess Laursen at christian.moess@wsj.com
-Christian Moess Laursen
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-04-23 0207ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Apple Earnings: iPhone Growth Forecasts Drive Change in Fair Value
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted